CurrentRheuma
Get Weekly

Topic · page 16 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 601–640 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

  1. Arthritis Res Ther

    Epidemiological trends in psoriatic arthritis: a comprehensive population-based study

    Cohort study

  2. RMD Open

    Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort

    Cohort study

  3. RMD Open

    Natural language processing to identify and characterize spondyloarthritis in clinical practice

    Cohort study

  4. Arthritis Res Ther

    Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis

    Secondary analysis

  5. Rheumatology (Oxford)

    Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development

    Cross-sectional study

  6. Joint Bone Spine

    Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop

    Guideline or statement

  7. Scand J Rheumatol

    Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response

    Cohort study

  8. Rheumatology (Oxford)

    Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry

    Cross-sectional study

  9. Rheumatology (Oxford)

    Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies

    Secondary analysis

  10. Arthritis Care Res (Hoboken)

    Sex Differences in Time to Initiate Nonsteroidal Anti‐Inflammatory Drugs or Biologic Disease‐Modifying Antirheumatic Drugs Among Patients With Axial Spondyloarthritis

    Cohort study

  11. J Rheumatol

    The Burden of Spine Structural Damage on Function in Patients With Axial Spondyloarthritis: Adaptation-Mediated Uncoupling?

    Cross-sectional study

  12. RMD Open

    Exploring complement biomarkers in suspected axial spondyloarthritis

    Cross-sectional study

  13. Ann Rheum Dis

    Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis

    Meta-analysis

  14. Ann Rheum Dis

    EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

    Guideline or statement

  15. Ann Rheum Dis

    MRI-based synthetic CT: a new method for structural damage assessment in the spine in patients with axial spondyloarthritis – a comparison with low-dose CT and radiography

    Diagnostic or prognostic study

  16. RMD Open

    Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status

    Secondary analysis

  17. Arthritis Care Res (Hoboken)

    Improvements in Patient‐Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial

    Randomized controlled trial

  18. Scand J Rheumatol

    Sacroiliitis in inflammatory bowel disease on abdominal computed tomography: prevalence, misses, and associated factors

    Cohort study

  19. Arthritis Rheumatol

    Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb Study

    Randomized controlled trial

  20. Arthritis Res Ther

    Sex-specific disparities in disease activity scores among patients with axial spondyloarthritis and their implications for evaluating the response to tumor necrosis factor alpha inhibitor therapy

    Cohort study

  21. RMD Open

    Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    Cohort study

  22. J Rheumatol

    Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?

    Cohort study

  23. Arthritis Rheumatol

    Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta‐Analysis

    Meta-analysis

  24. Ann Rheum Dis

    Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort

    Cohort study

  25. Ann Rheum Dis

    Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial

    Randomized controlled trial

  26. Ann Rheum Dis

    Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

    Guideline or statement

  27. Rheumatology (Oxford)

    Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort

    Cohort study

  28. RMD Open

    Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2

    Meta-analysis

  29. RMD Open

    Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage

    Cohort study

  30. Joint Bone Spine

    Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative

    Guideline or statement

  31. Clin Exp Rheumatol

    Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors

    Cohort study

  32. RMD Open

    High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort

    Cohort study

  33. Joint Bone Spine

    Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

    Cohort study

  34. Semin Arthritis Rheum

    Assessment of enthesopathy in conventional pelvis radiography: Another tool for spondyloarthritis diagnosis beyond sacroiliitis

    Diagnostic or prognostic study

  35. RMD Open

    Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging

    Diagnostic or prognostic study

  36. J Rheumatol

    Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis

    Guideline or statement

  37. J Rheumatol

    Patients With Psoriatic Arthritis–Related Enthesitis and Persistence on Tofacitinib Under Real-World Conditions

    Cohort study

  38. Clin Exp Rheumatol

    A new instrument for the screening of psoriatic arthritis among psoriatic patients

    Diagnostic or prognostic study

  39. Arthritis Care Res (Hoboken)

    Screening Tools for Spondyloarthritis in Patients With Psoriasis, Uveitis, and Inflammatory Bowel Disease: A Scoping Review

    Research article

  40. Semin Arthritis Rheum

    Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Cohort study

All 1,039 Briefs in ExploreShowing Briefs 601–640 of 1,039, newest first